rs147605088

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_005419.4(STAT2):​c.759C>T​(p.His253His) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00224 in 1,614,188 control chromosomes in the GnomAD database, including 10 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0016 ( 1 hom., cov: 31)
Exomes 𝑓: 0.0023 ( 9 hom. )

Consequence

STAT2
NM_005419.4 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -1.23

Publications

4 publications found
Variant links:
Genes affected
STAT2 (HGNC:11363): (signal transducer and activator of transcription 2) The protein encoded by this gene is a member of the STAT protein family. In response to cytokines and growth factors, STAT family members are phosphorylated by the receptor associated kinases, and then form homo- or heterodimers that translocate to the cell nucleus where they act as transcription activators. In response to interferon (IFN), this protein forms a complex with STAT1 and IFN regulatory factor family protein p48 (ISGF3G), in which this protein acts as a transactivator, but lacks the ability to bind DNA directly. The protein mediates innate antiviral activity. Mutations in this gene result in Immunodeficiency 44. [provided by RefSeq, Aug 2020]
STAT2 Gene-Disease associations (from GenCC):
  • primary immunodeficiency with post-measles-mumps-rubella vaccine viral infection
    Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: PanelApp Australia, G2P, Orphanet, Labcorp Genetics (formerly Invitae)
  • pseudo-TORCH syndrome 3
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 12-56354489-G-A is Benign according to our data. Variant chr12-56354489-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 403494.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.23 with no splicing effect.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00164 (250/152310) while in subpopulation AMR AF = 0.0036 (55/15298). AF 95% confidence interval is 0.00284. There are 1 homozygotes in GnomAd4. There are 108 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 9 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_005419.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
STAT2
NM_005419.4
MANE Select
c.759C>Tp.His253His
synonymous
Exon 8 of 24NP_005410.1P52630-3
STAT2
NM_198332.2
c.747C>Tp.His249His
synonymous
Exon 8 of 24NP_938146.1P52630-4
STAT2
NM_001385114.1
c.759C>Tp.His253His
synonymous
Exon 8 of 23NP_001372043.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
STAT2
ENST00000314128.9
TSL:1 MANE Select
c.759C>Tp.His253His
synonymous
Exon 8 of 24ENSP00000315768.4P52630-3
STAT2
ENST00000922389.1
c.759C>Tp.His253His
synonymous
Exon 8 of 24ENSP00000592448.1
STAT2
ENST00000960656.1
c.756C>Tp.His252His
synonymous
Exon 8 of 24ENSP00000630715.1

Frequencies

GnomAD3 genomes
AF:
0.00164
AC:
250
AN:
152192
Hom.:
1
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.000555
Gnomad AMI
AF:
0.00329
Gnomad AMR
AF:
0.00360
Gnomad ASJ
AF:
0.00288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00104
Gnomad FIN
AF:
0.000283
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00215
Gnomad OTH
AF:
0.00239
GnomAD2 exomes
AF:
0.00209
AC:
526
AN:
251462
AF XY:
0.00211
show subpopulations
Gnomad AFR exome
AF:
0.000554
Gnomad AMR exome
AF:
0.00382
Gnomad ASJ exome
AF:
0.00318
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000323
Gnomad NFE exome
AF:
0.00254
Gnomad OTH exome
AF:
0.00310
GnomAD4 exome
AF:
0.00231
AC:
3373
AN:
1461878
Hom.:
9
Cov.:
32
AF XY:
0.00230
AC XY:
1670
AN XY:
727240
show subpopulations
African (AFR)
AF:
0.000209
AC:
7
AN:
33480
American (AMR)
AF:
0.00402
AC:
180
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00341
AC:
89
AN:
26136
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39700
South Asian (SAS)
AF:
0.00133
AC:
115
AN:
86256
European-Finnish (FIN)
AF:
0.000262
AC:
14
AN:
53418
Middle Eastern (MID)
AF:
0.000695
AC:
4
AN:
5758
European-Non Finnish (NFE)
AF:
0.00252
AC:
2799
AN:
1112012
Other (OTH)
AF:
0.00270
AC:
163
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
209
419
628
838
1047
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
102
204
306
408
510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00164
AC:
250
AN:
152310
Hom.:
1
Cov.:
31
AF XY:
0.00145
AC XY:
108
AN XY:
74472
show subpopulations
African (AFR)
AF:
0.000553
AC:
23
AN:
41578
American (AMR)
AF:
0.00360
AC:
55
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00288
AC:
10
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.00104
AC:
5
AN:
4824
European-Finnish (FIN)
AF:
0.000283
AC:
3
AN:
10612
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00215
AC:
146
AN:
68030
Other (OTH)
AF:
0.00237
AC:
5
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
11
23
34
46
57
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00224
Hom.:
0
Bravo
AF:
0.00237
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.00289
EpiControl
AF:
0.00279

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
4
not provided (4)
-
-
1
not specified (1)
-
-
1
Primary immunodeficiency with post-measles-mumps-rubella vaccine viral infection (1)
-
-
1
STAT2-related disorder (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
2.4
DANN
Benign
0.73
PhyloP100
-1.2
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs147605088; hg19: chr12-56748273; COSMIC: COSV58475353; COSMIC: COSV58475353; API